Company: ATHE
Filing Date: 2025-08-29
Form Type: 20-F
Source: 0001213900-25-082027
Chunk: 122

Company: ALTERITY THERAPEUTICS LTD
Filing Date: 2025-08-29
Form: 20-F
Item: Item 16G
Chunk 122
---
ITEM 16G. CORPORATE GOVERNANCE

Under NASDAQ Stock Market Rule 5615(a)(3), foreign
private issuers, such as our company, are permitted to follow certain home country (Australian) corporate governance practices instead
of certain provisions of the NASDAQ Stock Market Rules. A foreign private issuer that elects to follow a home country practice instead
of any NASDAQ rule must submit to NASDAQ, in advance, a written statement from an independent counsel in such issuer’s home country
certifying that the issuer’s practices are not prohibited by the home country’s laws. We have submitted a notice to NASDAQ
informing them of that we elect to follow home country practice instead of the following NASDAQ rules:

  the Rule related to Audit Committee Composition rule 5605(c)(2)(A)): we may have an audit committee composed of two members instead of “at least three members”. We may not follow NASDAQ rules r...  

  the Rule requiring maintaining a majority of independent directors (Rule 5605(b)(1))  

  the Rule requiring that our independent directors have regularly scheduled meetings at which only independent directors are present (Rule 56505(b)(2)  

  the Rule regarding independent director oversight of director nominations process for directors (Rule 5605(e)  

  the Rule regarding independent director oversight of executive officer compensation (Rule 5605(d)  

  the requirement to obtain shareholder approval for the establishment or amendment of certain equity based compensation plans (Rule 5635(c), an issuance that will result in a change of control o...  

ITEM 16H. MINE SAFETY DISCLOSURE